Cargando…
SETMAR Shorter Isoform: A New Prognostic Factor in Glioblastoma
Recent evidence suggests that the chimeric protein SETMAR is a factor of interest in cancer, especially in glioblastoma. However, little is known about the expression of this protein in glioblastoma tissues, and no study has been done to assess if SETMAR could be a prognostic and/or diagnostic marke...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761672/ https://www.ncbi.nlm.nih.gov/pubmed/35047379 http://dx.doi.org/10.3389/fonc.2021.638397 |